Opportunity Information: Apply for PAR 28 091

The National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), is offering support through a grant mechanism called an R33 (Clinical Trial Required) for teams that want to run early-phase, multi-site feasibility clinical trials of mind and body interventions. In this announcement, mind and body interventions refers to complementary and integrative health approaches that involve physical and/or psychological therapeutic inputs, and the central scientific emphasis is on emotional well-being (EWB) as a set of mechanisms that may help explain how these interventions contribute to whole person health restoration. The overall intent is not to fund a large definitive efficacy trial yet, but to build the practical and scientific groundwork needed for later, larger clinical trials that can credibly test outcomes and perform mechanistic mediation analyses.

A core feature of this opportunity is its focus on reproducibility and translation across multiple sites. Applicants are expected to use a multi-site design to show that an intervention can be delivered consistently (with fidelity) in different real-world research environments, and that the same hypothesized EWB mechanisms can be engaged in a rigorous and reproducible way at each site. This reflects NCCIHs interest in moving beyond single-site proof-of-concept studies toward designs that better anticipate the operational complexity and variability that show up in large-scale trials. In practice, this means the application should pay close attention to standardization of intervention delivery, training and certification procedures for interventionists, quality assurance monitoring, and harmonized protocols so that results are interpretable when data are pooled across sites.

The NOFO lays out several concrete feasibility targets that these early-phase trials should address. First, studies need to demonstrate cross-site intervention fidelity, meaning the intervention is delivered as intended and in a comparable way at every participating location. Second, they must test whether the proposed emotional well-being mechanisms are actually engaged by the intervention across sites, using measures and procedures that are strong enough to support later mechanistic testing. Third, projects should evaluate recruitment, retention, and randomization feasibility, since these operational factors often determine whether a later full-scale trial is realistic. Fourth, applicants should assess the feasibility of collecting both comprehensive clinical outcome data relevant to whole person health restoration and mechanistic EWB data across all sites, which implies harmonized assessment schedules, consistent data collection procedures, and workable data management plans. Fifth, while the trial is still considered feasibility-focused, investigators are encouraged to explore relationships between changes in mechanistic targets and changes in clinical outcomes using pooled data across sites, which helps generate evidence that the mechanism and the outcomes move together in the way the theory predicts.

In terms of scope, this program is essentially asking applicants to bridge two needs at once: operational readiness for multi-site research and scientifically credible measurement of mechanisms related to emotional well-being. Successful applications will typically make a clear case for why a specific mind and body intervention should influence specific EWB mechanisms, explain how those mechanisms are measured consistently, and show that the team can run a coordinated multi-site study with strong data quality. The longer-term payoff NCCIH is aiming for is a pipeline of well-prepared interventions and research teams that can go on to run large, rigorous clinical trials capable of testing whole person health outcomes and formally evaluating whether EWB mechanisms mediate those outcomes.

The funding opportunity is listed as PAR 28 091, uses a grant funding instrument, and falls under NIH health research activity areas (CFDA numbers 93.213 and 93.473). The posted award ceiling is $500,000, and the opportunity is open for submissions until an original closing date of 2029-11-16. Eligibility is broad within the United States and includes state and local governments, tribal governments and certain tribal organizations, public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), and for-profit organizations (including small businesses, though the listing specifies for-profits other than small businesses as well). As a strict limitation, non-U.S. organizations are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components are not allowed as defined by NIH policy. For details beyond the summary, applicants are directed to consult Section III of the NOFO for the complete eligibility requirements and any additional constraints.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.473.
  • This funding opportunity was created on 2026-10-15.
  • Applicants must submit their applications by 2029-11-16.
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 28 091

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What agency is offering this funding opportunity?

This opportunity is offered by the National Center for Complementary and Integrative Health (NCCIH), which is part of the National Institutes of Health (NIH).

What is the funding mechanism for this opportunity?

The grant mechanism is an R33 (Clinical Trial Required).

What is the focus of the clinical trials supported by this R33?

The program supports early-phase, multi-site feasibility clinical trials of mind and body interventions, with the central scientific emphasis on emotional well-being (EWB) as a set of mechanisms that may help explain how these interventions contribute to whole person health restoration.

How does this opportunity define "mind and body interventions"?

In this announcement, mind and body interventions refer to complementary and integrative health approaches that involve physical and/or psychological therapeutic inputs.

Is this opportunity intended to fund a large, definitive efficacy trial?

No. The overall intent is to build the practical and scientific groundwork needed for later, larger clinical trials, rather than to fund a large definitive efficacy trial at this stage.

Why does the opportunity emphasize emotional well-being (EWB)?

The emphasis is on EWB as a set of mechanisms that may help explain how mind and body interventions contribute to whole person health restoration, and to enable later mechanistic mediation analyses in larger trials.

Does the trial have to be multi-site?

Yes. A core feature of the opportunity is reproducibility and translation across multiple sites, and applicants are expected to use a multi-site design.

What is NCCIH looking for in a multi-site design?

The application is expected to show that an intervention can be delivered consistently (with fidelity) across different sites and that the same hypothesized EWB mechanisms can be engaged in a rigorous and reproducible way at each site.

What does "intervention fidelity" mean in this announcement?

Intervention fidelity refers to demonstrating that the intervention is delivered as intended and in a comparable way at every participating location.

What kinds of operational planning are expected for cross-site reproducibility?

The summary emphasizes planning for standardization of intervention delivery, training and certification procedures for interventionists, quality assurance monitoring, and harmonized protocols so pooled cross-site results are interpretable.

What feasibility targets are specifically called out in the NOFO summary?

The summary highlights several feasibility targets: (1) cross-site intervention fidelity, (2) testing whether proposed EWB mechanisms are engaged across sites, (3) recruitment, retention, and randomization feasibility, (4) feasibility of collecting comprehensive clinical outcome data and mechanistic EWB data across sites with harmonized procedures and workable data management, and (5) exploring relationships between changes in mechanistic targets and changes in clinical outcomes using pooled multi-site data.

Are applicants expected to measure EWB mechanisms in a way that supports later mechanistic testing?

Yes. The trials must test whether the proposed EWB mechanisms are actually engaged by the intervention across sites using measures and procedures strong enough to support later mechanistic testing.

What operational metrics should a feasibility trial address under this opportunity?

The summary specifies recruitment feasibility, retention feasibility, and randomization feasibility as key operational factors to evaluate.

What types of data collection feasibility should be addressed?

Applicants should assess the feasibility of collecting both comprehensive clinical outcome data relevant to whole person health restoration and mechanistic EWB data across all sites, including harmonized assessment schedules, consistent data collection procedures, and workable data management plans.

Are teams encouraged to analyze pooled data across sites?

Yes. While the trial is feasibility-focused, investigators are encouraged to explore relationships between changes in mechanistic targets and changes in clinical outcomes using pooled data across sites.

What is the longer-term goal NCCIH is aiming for with this program?

The longer-term aim is a pipeline of well-prepared interventions and research teams ready to run large, rigorous clinical trials capable of testing whole person health outcomes and formally evaluating whether EWB mechanisms mediate those outcomes.

What is the funding opportunity number or identifier?

The opportunity is listed as PAR 28 091.

What type of funding instrument is used?

The listing indicates it uses a grant funding instrument.

What are the CFDA numbers associated with this opportunity?

The opportunity falls under NIH health research activity areas with CFDA numbers 93.213 and 93.473.

What is the posted award ceiling?

The posted award ceiling is $500,000.

What is the submission deadline or closing date?

The opportunity is open for submissions until an original closing date of 2029-11-16.

Who is eligible to apply within the United States?

Eligibility is broad and includes state and local governments, tribal governments and certain tribal organizations, public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), and for-profit organizations (including small businesses, and also for-profits other than small businesses as specified in the listing).

Are non-U.S. organizations eligible to apply?

No. Non-U.S. organizations are not eligible to apply.

Are non-U.S. components of U.S. organizations allowed?

No. Non-U.S. components of U.S. organizations are not eligible.

Are foreign components allowed under NIH policy?

No. Foreign components are not allowed as defined by NIH policy.

Where should applicants look for complete eligibility requirements and constraints?

For details beyond the summary, applicants are directed to consult Section III of the NOFO for complete eligibility requirements and any additional constraints.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Dairy Business Innovation Initiatives Program (DBI) Fiscal Year 2026

Previous opportunity: NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 28 091

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 28 091) also looked into and applied for these:

Funding Opportunity
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) Apply for RFA DA 28 011

Funding Number: RFA DA 28 011
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) Apply for RFA DA 28 012

Funding Number: RFA DA 28 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) Apply for RFA NS 28 010

Funding Number: RFA NS 28 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) Apply for PAR 28 022

Funding Number: PAR 28 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) Apply for RFA DA 28 013

Funding Number: RFA DA 28 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) Apply for RFA DK 27 122

Funding Number: RFA DK 27 122
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) Apply for PAR 27 090

Funding Number: PAR 27 090
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) Apply for PAR 28 090

Funding Number: PAR 28 090
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) Apply for RFA AI 27 018

Funding Number: RFA AI 27 018
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) Apply for RFA CA 28 013

Funding Number: RFA CA 28 013
Agency: National Institutes of Health
Category: Health
Funding Amount: $700,000
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) Apply for RFA AI 28 031

Funding Number: RFA AI 28 031
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,500,000
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) Apply for RFA CA 28 004

Funding Number: RFA CA 28 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 28 001

Funding Number: RFA AA 28 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,150,000
NIH Research Program Projects (Parent P01 Clinical Trial Optional) Apply for PA 27 061

Funding Number: PA 27 061
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) Apply for PAR 27 045

Funding Number: PAR 27 045
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) Apply for RFA LM 28 001

Funding Number: RFA LM 28 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $775,000
Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) Apply for PAR 27 003

Funding Number: PAR 27 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed) Apply for RFA RM 27 024

Funding Number: RFA RM 27 024
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) Apply for PAR 28 014

Funding Number: PAR 28 014
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) Apply for RFA RM 27 025

Funding Number: RFA RM 27 025
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 28 091", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: